Center for Scientific Review; Notice of Closed Meetings, 27640-27641 [2019-12474]
Download as PDF
<![CDATA[
27640
Federal Register / Vol. 84, No. 114 / Thursday, June 13, 2019 / Notices
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN—Continued
Number of
respondents
Activity
Number of
responses
per
respondent
Total annual
responses
Total hours
Total capital
costs
Supplement to approved plan ...........................................................................
10
1
10
30
300
120
Total ...........................................................................................................
....................
....................
....................
....................
540
168
FDA estimates a total of 4 respondents
will submit a new original warning plan
and take 60 hours to complete a
rotational warning plan for a total of 240
burden hours. In addition, 10
respondents will submit a supplement
to an approved warning plan at 30 hours
per response for a total of 300 hours.
The total burden for this collection is
estimated to be 540 hours.
Capital costs are based on 14
respondents mailing in their submission
at a postage rate of $12 for a 5-pound
parcel (business parcel post mail
delivered from the furthest delivery
zone). Therefore, FDA estimates that the
total postage cost for mailing the
rotational warning plans FDA to be
$168.
We have adjusted our burden
estimate, which has resulted in a
decrease of 5,460 hours and 86
respondents to the currently approved
burden. We received a total number of
44 original smokeless warning plans,
and a total of 17 supplements. After
receiving the initial influx of original
warnings plans, FDA does not expect to
receive as many original warning plans
annually. We expect that a few
supplements will continue to be
received as new products are marketed
or as warning plans are revised. We
anticipate a total number of 10
supplements submitted annually and 4
original smokeless warning plans.
Dated: June 7, 2019.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
The Office of the Assistant
Secretary for Health published a
document in the Federal Register of
June 3, 2019, announcing the Pain
Management Best Practices InterAgency Task Force’s virtual public
meeting. This document is announcing
a change in the meeting date.
FOR FURTHER INFORMATION CONTACT: Ms.
Alicia Richmond Scott, 240–453–2816;
paintaskforce@hhs.gov.
SUPPLEMENTARY INFORMATION:
SUMMARY:
Correction
In the Federal Register of June 3,
2019, in FR Doc. 2019–11473, on page
25548, in the first column, correct the
DATES caption to read:
DATES: The Task Force meeting will be
held on Wednesday, June 26, 2019 from
5:00 p.m. to 6:30 p.m. Eastern Time
(ET). The agenda will be posted on the
Task Force website at https://
www.hhs.gov/ash/advisory-committees/
pain/.
Dated: June 6, 2019.
Vanila M. Singh,
Chief Medical Officer, Chair, Pain
Management Best Practices Inter-Agency
Task Force, Office of the Assistant Secretary
for Health.
[FR Doc. 2019–12482 Filed 6–12–19; 8:45 am]
BILLING CODE 4150–28–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
[FR Doc. 2019–12472 Filed 6–12–19; 8:45 am]
BILLING CODE 4164–01–P
Center for Scientific Review; Notice of
Closed Meetings
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
Office of the Assistant Secretary for
Health
khammond on DSKBBV9HB2PROD with NOTICES
Average
burden per
response
Meeting of the Pain Management Best
Practices Inter-Agency Task Force;
Correction
Office of the Assistant
Secretary for Health, Office of the
Secretary, Department of Health and
Human Services.
ACTION: Notice; correction.
AGENCY:
VerDate Sep<11>2014
16:55 Jun 12, 2019
Jkt 247001
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR17–094:
Maximizing Investigators’ Research Award
(R35).
Date: July 9, 2019.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel
Conference Center, Montgomery County
Conference Center Facility, 5701 Marinelli
Road, North Bethesda, MD 20852.
Contact Person: Baishali Maskeri, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2022,
Bethesda, MD 20892, 301–827–2864,
maskerib@mail.nih.gov
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA Panel:
Healthy Brain and Child Development Study
(Healthy BCD).
Date: July 11, 2019.
Time: 8:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Capital View, 2850
South Potomac Avenue, Arlington, VA 22202
Contact Person: Heidi B. Friedman, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1012A,
MSC 7770, Bethesda, MD 20892, 301–379–
5632, hfriedman@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Chronic Disease and the Reduction of Health
Disparities.
Date: July 12, 2019.
Time: 10:30 a.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Karen Nieves Lugo, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, Bethesda, MD 20892,
karen.nieveslugo@nih.gov.
Name of Committee: AIDS and Related
Research Integrated Review Group;
Population and Public Health Approaches to
HIV/AIDS Study Section
Date: July 15–16, 2019.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications,
Place: Hotel Nikko San Francisco, 222
Mason Street, San Francisco, CA 94102
Contact Person: Jose H. Guerrier, Ph.D.,
Scientific Review Officer, Center for
E:\FR\FM\13JNN1.SGM
13JNN1
khammond on DSKBBV9HB2PROD with NOTICES
Federal Register / Vol. 84, No. 114 / Thursday, June 13, 2019 / Notices
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5222,
MSC 7852, Bethesda, MD 20892, 301–435–
1137, guerriej@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Neuroscience Assay, Diagnostics
and Animal Model Development.
Date: July 15–16, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Sir Francis Drake Hotel, 450 Powell
Street at Kimpton Hotel, San Francisco, CA
94102.
Contact Person: Susan Gillmor, Ph.D.,
Scientific Review Officer, National Institutes
of Health, Center for Scientific Review, 6701
Rockledge Drive, Bethesda, MD 20892, 240–
762–3076, susan.gillmor@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Human-Animal Interaction (HAI) Research.
Date: July 15, 2019.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, RKL II,
6701 Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Biao Tian, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 3089B, MSC 7848, Bethesda,
MD 20892, (301) 402–4411, tianbi@
csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Cell Biology, Developmental
Biology, and Bioengineering.
Date: July 16–17, 2019.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel Bethesda
(Formerly Holiday Inn Select), 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Alexander Gubin, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4196,
MSC 7812, Bethesda, MD 20892, 301–435–
2902, gubina@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Topics in
Bacterial Pathogenesis.
Date: July 16, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Drury Plaza Hotel by the Arch, 2nd
and 4th Street, St. Louis, MO 63102.
Contact Person: Richard G. Kostriken,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3192,
MSC 7808, Bethesda, MD 20892, 240–519–
7808, kostrikr@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA–AI–
18–054 U.S.-Brazil Collaborative Biomedical
Research Program.
Date: July 16, 2019.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Sep<11>2014
16:55 Jun 12, 2019
Jkt 247001
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Andrea Keane-Myers,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4218,
Bethesda, MD 20892, 301–435–1221,
andrea.keane-myers@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Lung Injury
and Fibrosis.
Date: July 16–17, 2019.
Time: 9:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, RKL II,
6701 Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: George M. Barnas, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4220,
MSC 7818, Bethesda, MD 20892, 301–435–
0696, barnasg@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Topics in
Drug Discovery and Clinical Field Studies.
Date: July 16, 2019.
Time: 9:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Liangbiao Zheng, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3202,
MSC 7808, Bethesda, MD 20892, 301–996–
5819, zhengli@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR 16–
121: Early-Stage Preclinical Validation of
Therapeutic Leads for Diseases of Interest to
the NIDDK.
Date: July 16, 2019.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Antonello Pileggi, MD,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6166,
Bethesda, MD 20892–7892, (301) 402–6297,
pileggia@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Topics in Virology.
Date: July 16, 2019.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Marci Scidmore, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3192,
MSC 7808, Bethesda, MD 20892, 301–435–
1149, marci.scidmore@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR 16–
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
27641
121: Early-Stage Preclinical Validation of
Therapeutic Leads for Diseases of Interest to
the NIDDK.
Date: July 16, 2019.
Time: 5:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Elaine Sierra-Rivera, Ph.D.,
Scientific Review Officer, EMNR IRG, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6182
MSC 7892, Bethesda, MD 20892, 301 435–
2514, riverase@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: June 7, 2019.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–12474 Filed 6–12–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
U.S. Customs and Border Protection
[1651–0032]
Agency Information Collection
Activities: Importers of Merchandise
Subject to Actual Use Provisions
U.S. Customs and Border
Protection (CBP), Department of
Homeland Security.
ACTION: 30-Day notice and request for
comments; extension of an existing
collection of information.
AGENCY:
The Department of Homeland
Security, U.S. Customs and Border
Protection will be submitting the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995 (PRA). The
information collection is published in
the Federal Register to obtain comments
from the public and affected agencies.
Comments are encouraged and must be
submitted (no later than July 15, 2019 to
be assured of consideration.
ADDRESSES: Interested persons are
invited to submit written comments on
this proposed information collection to
the Office of Information and Regulatory
Affairs, Office of Management and
Budget. Comments should be addressed
to the OMB Desk Officer for Customs
and Border Protection, Department of
Homeland Security, and sent via
SUMMARY:
E:\FR\FM\13JNN1.SGM
13JNN1
]]>Agencies
[Federal Register Volume 84, Number 114 (Thursday, June 13, 2019)]
[Notices]
[Pages 27640-27641]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-12474]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR17-094: Maximizing Investigators' Research Award (R35).
Date: July 9, 2019.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel Conference Center,
Montgomery County Conference Center Facility, 5701 Marinelli Road,
North Bethesda, MD 20852.
Contact Person: Baishali Maskeri, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2022, Bethesda, MD 20892, 301-
827-2864, [email protected]
Name of Committee: Center for Scientific Review Special Emphasis
Panel; RFA Panel: Healthy Brain and Child Development Study (Healthy
BCD).
Date: July 11, 2019.
Time: 8:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Residence Inn Capital View, 2850 South Potomac Avenue,
Arlington, VA 22202
Contact Person: Heidi B. Friedman, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1012A, MSC 7770, Bethesda, MD
20892, 301-379-5632, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR Panel: Chronic Disease and the Reduction of Health
Disparities.
Date: July 12, 2019.
Time: 10:30 a.m. to 3:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Karen Nieves Lugo, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, Bethesda, MD 20892, [email protected].
Name of Committee: AIDS and Related Research Integrated Review
Group; Population and Public Health Approaches to HIV/AIDS Study
Section
Date: July 15-16, 2019.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications,
Place: Hotel Nikko San Francisco, 222 Mason Street, San
Francisco, CA 94102
Contact Person: Jose H. Guerrier, Ph.D., Scientific Review
Officer, Center for
[[Page 27641]]
Scientific Review, National Institutes of Health, 6701 Rockledge
Drive, Room 5222, MSC 7852, Bethesda, MD 20892, 301-435-1137,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Neuroscience Assay, Diagnostics and Animal
Model Development.
Date: July 15-16, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Sir Francis Drake Hotel, 450 Powell Street at Kimpton
Hotel, San Francisco, CA 94102.
Contact Person: Susan Gillmor, Ph.D., Scientific Review Officer,
National Institutes of Health, Center for Scientific Review, 6701
Rockledge Drive, Bethesda, MD 20892, 240-762-3076,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR Panel: Human-Animal Interaction (HAI) Research.
Date: July 15, 2019.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, RKL II, 6701 Rockledge
Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Biao Tian, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3089B, MSC 7848, Bethesda, MD 20892, (301)
402-4411, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fellowships: Cell Biology, Developmental Biology, and
Bioengineering.
Date: July 16-17, 2019.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Doubletree Hotel Bethesda (Formerly Holiday Inn Select),
8120 Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Alexander Gubin, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4196, MSC 7812, Bethesda, MD
20892, 301-435-2902, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Topics in Bacterial Pathogenesis.
Date: July 16, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Drury Plaza Hotel by the Arch, 2nd and 4th Street, St.
Louis, MO 63102.
Contact Person: Richard G. Kostriken, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3192, MSC 7808, Bethesda, MD
20892, 240-519-7808, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; RFA-AI-18-054 U.S.-Brazil Collaborative Biomedical Research
Program.
Date: July 16, 2019.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Andrea Keane-Myers, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4218, Bethesda, MD 20892, 301-
435-1221, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Lung Injury and Fibrosis.
Date: July 16-17, 2019.
Time: 9:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, RKL II, 6701 Rockledge
Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: George M. Barnas, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4220, MSC 7818, Bethesda, MD
20892, 301-435-0696, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Topics in Drug Discovery and Clinical Field Studies.
Date: July 16, 2019.
Time: 9:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892.
Contact Person: Liangbiao Zheng, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3202, MSC 7808, Bethesda, MD
20892, 301-996-5819, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR 16-121: Early-Stage Preclinical Validation of Therapeutic
Leads for Diseases of Interest to the NIDDK.
Date: July 16, 2019.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Antonello Pileggi, MD, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6166, Bethesda, MD 20892-7892,
(301) 402-6297, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Topics in Virology.
Date: July 16, 2019.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Marci Scidmore, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3192, MSC 7808, Bethesda, MD
20892, 301-435-1149, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR 16-121: Early-Stage Preclinical Validation of Therapeutic
Leads for Diseases of Interest to the NIDDK.
Date: July 16, 2019.
Time: 5:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Elaine Sierra-Rivera, Ph.D., Scientific Review
Officer, EMNR IRG, Center for Scientific Review, National Institutes
of Health, 6701 Rockledge Drive, Room 6182 MSC 7892, Bethesda, MD
20892, 301 435-2514, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: June 7, 2019.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-12474 Filed 6-12-19; 8:45 am]
BILLING CODE 4140-01-P
